Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors
Important problem for the cardiologist and the first contact a doctor (therapist and general practitioner) is to optimize the therapeutic and preventive aspects of drug therapy in patients with coronary heart disease and arterial hypertension. The article considers the question of choice of ACE inhi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Morozov P.V.
2014-03-01
|
| Series: | Системные гипертензии |
| Subjects: | |
| Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/29016/pdf |
| _version_ | 1818891246193606656 |
|---|---|
| author | D I Trukhan L V Tarasova |
| author_facet | D I Trukhan L V Tarasova |
| author_sort | D I Trukhan |
| collection | DOAJ |
| description | Important problem for the cardiologist and the first contact a doctor (therapist and general practitioner) is to optimize the therapeutic and preventive aspects of drug therapy in patients with coronary heart disease and arterial hypertension. The article considers the question of choice of ACE inhibitor from the standpoint of rational pharmacotherapy and evidence-based medicine. |
| first_indexed | 2024-12-19T17:37:45Z |
| format | Article |
| id | doaj.art-8d9d6b2a9279446c872780a7f31c4683 |
| institution | Directory Open Access Journal |
| issn | 2075-082X 2542-2189 |
| language | Russian |
| last_indexed | 2024-12-19T17:37:45Z |
| publishDate | 2014-03-01 |
| publisher | IP Morozov P.V. |
| record_format | Article |
| series | Системные гипертензии |
| spelling | doaj.art-8d9d6b2a9279446c872780a7f31c46832022-12-21T20:12:17ZrusIP Morozov P.V.Системные гипертензии2075-082X2542-21892014-03-01111737726117Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitorsD I TrukhanL V TarasovaImportant problem for the cardiologist and the first contact a doctor (therapist and general practitioner) is to optimize the therapeutic and preventive aspects of drug therapy in patients with coronary heart disease and arterial hypertension. The article considers the question of choice of ACE inhibitor from the standpoint of rational pharmacotherapy and evidence-based medicine.https://syst-hypertension.ru/2075-082X/article/viewFile/29016/pdfhypertensioncoronary heart diseasetreatment optimizationangiotensin-converting enzyme inhibitorsperindoprilprestarium® a |
| spellingShingle | D I Trukhan L V Tarasova Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors Системные гипертензии hypertension coronary heart disease treatment optimization angiotensin-converting enzyme inhibitors perindopril prestarium® a |
| title | Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
| title_full | Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
| title_fullStr | Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
| title_full_unstemmed | Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
| title_short | Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
| title_sort | optimization of drug therapy of coronary heart disease and arterial hypertension choice angiotensin converting enzyme inhibitors |
| topic | hypertension coronary heart disease treatment optimization angiotensin-converting enzyme inhibitors perindopril prestarium® a |
| url | https://syst-hypertension.ru/2075-082X/article/viewFile/29016/pdf |
| work_keys_str_mv | AT ditrukhan optimizationofdrugtherapyofcoronaryheartdiseaseandarterialhypertensionchoiceangiotensinconvertingenzymeinhibitors AT lvtarasova optimizationofdrugtherapyofcoronaryheartdiseaseandarterialhypertensionchoiceangiotensinconvertingenzymeinhibitors |